Their pleiotropic effects, which include the capability to attenuate the proinflammatory response of cytokines, such as interleukin 6 (IL-6), and to decrease neutrophil influx, as well as to improve the cardiovascular complication, make them potential and intriguing candidates for CoV treatment, particularly for the new COVID-19 outbreak treatment (Weitz-Schmidt, 2002; Fedson et al., 2020). This evidence concerns the gene IL6 and COVID-19.